Abstract
RSV is the main viral respiratory cause of hospitalization in infants and young children in the United States and in the world. This manuscript discusses the different established and experimental approaches to prevention and treatment of respiratory syncytial virus disease. Therapeutic and preventive strategies are examined considering the mechanisms of viral pathogenesis and protection.
Keywords: respiratory tract infections, immunity, ribavirin, bronchodilators
Article Metrics
11